Recent Progresses in Analytical Perspectives of Degradation Studies and Impurity Profiling in Pharmaceutical Developments: An Updated Review

References

• International Conference on Harmonisation (ICH), Impurities in New Drug Products Q3B (R2), IFPMA, Geneva (Switzerland), 2006.
   Google Scholar
• International Conference on Harmonisation (ICH), Impurities in New Drug Substances Q3A (R2) IFPMA, Geneva (Switzerland), 2006.
   Google Scholar
• International Conference on Harmonisation (ICH), Stability Testing of New Drug Substances and Products Q1A (R2) (Revised Guideline), 2003.
   Google Scholar
• International Conference on Harmonisation (ICH), Photostability Testing of New Drug Substances and Products ICH Q1B, 1999.
   Google Scholar
• International Conference on Harmonisation (ICH), Stability Testing for New Dosage Forms ICH Q1C, 1997.
   Google Scholar
• International Conference on Harmonisation (ICH), Evaluation of Stability Data ICH Q1E, 2004.
   Google Scholar
• Müller, L.; Mauthe, R. J.; Riley, C. M.; Andino, M. M.; Antonis, D. D.; Beels, C.; DeGeorge, J.; Knaep, A. G. M. D.; Ellison, D.; Fagerland, J. A.; et al. A Rationale for Determining, Testing, and Controlling Specific Impurities in Pharmaceuticals That Possess Potential for Genotoxicity. Regul. Toxicol. Pharmacol. 2006, 44, 198–211. DOI: 10.1016/j.yrtph.2005.12.001.
   PubMed Web of Science ®Google Scholar
• Gross, J. M. Fanconi Syndrome (Adult Type) Developing Secondary to the Ingestion of Outdated Tetracycline. Ann. Intern. Med. 1963, 58, 523–528. DOI: 10.7326/0003-4819-58-3-523.
   PubMed Web of Science ®Google Scholar
• Betto, P.; Turchetto, L.; Longinotti, L. Allergenic Impurities in Medicinal Preparations Containing Aminopenicillin. I. Ampicillin Sodium. Ann. Ist. Super. Sanita. 1989, 25, 315–317.
   PubMedGoogle Scholar
• Romano, A.; Torres, M. J.; Fernandez, J.; Vega, J. M.; Mayorga, C.; Garcia, J.; Blanca, M. Allergic Reactions to Ampicillin. Studies on the Specificity and Selectivity in Subjects with Immediate Reactions. Clin. Exp. Allergy. 1997, 27, 1425–1431. DOI: 10.1046/j.1365-2222.1997.1790983.x
   PubMed Web of Science ®Google Scholar
• McMahon, A. W.; Pratt, R. G.; Hammad, T. A.; Kozlowski, S.; Zhou, E.; Lu, S.; Kulick, C. G.; Mallick, T.; Pan, G. D. Description of Hypersensitivity Adverse Events following Administration of Heparin That Was Potentially Contaminated with Oversulfated Chondroitin Sulfate in Early 2008. Pharmacoepidemiol Drug Saf. 2010, 19, 921–933. DOI: 10.1002/pds.1991.
   PubMed Web of Science ®Google Scholar
• Görög, S. Critical Review of Reports on Impurity and Degradation Product Profiling in the Last Decade. Trends. Analyt. Chem. 2018, 101, 2–16. DOI: 10.1016/j.trac.2017.09.012.
   Web of Science ®Google Scholar
• Roy, J. Pharmaceutical Impurities—A Mini-Review. AAPs. Pharm. Sci. Tech. 2002, 3, 1–8. DOI: 10.1208/pt030206.
   Google Scholar
• The United State Pharmacopeial USP 41. The National Formulary NF 41, 2018; United State Pharmacopeial Convention, Inc.: Rockville, MD, 1990, pp. 1434–1435.
   Google Scholar
• Khodaverdi, E.; Golmohammadian, A.; Mohajeri, S. A.; Zohuri, G.; Tekie, M.; Hadizadeh, F. Biodegradable in Situ Gel-Forming Controlled Drug Delivery System Based on Thermosensitive Poly(ε-Caprolactone)-Poly(Ethylene Glycol)-Poly(ε-Caprolactone) Hydrogel. ISRN Pharm. 2012, 2012, 976879. DOI: 5402/2012/976879 DOI: 10.5402/2012/976879.
   PubMedGoogle Scholar
• Ahuja, S. S. Assuring Quality of Drugs by Monitoring Impurities. Adv. Drug Deliv. Rev. 2007, 59, 3–11. DOI: 10.1016/j.addr.2006.10.003.
   PubMed Web of Science ®Google Scholar
• Alsante, K. M.; Ando, A.; Brown, R.; Ensing, J.; Hatajik, T. D.; Kong, W.; Tsuda, Y. The Role of Degradant Profiling in Active Pharmaceutical Ingredients and Drug Products. Adv. Drug Deliv. Rev. 2007, 59, 29–37. DOI: 10.1016/j.addr.2006.10.006.
   PubMed Web of Science ®Google Scholar
• Dhangar, K. R.; Jagtap, R. B.; Surana, S. J.; Shirkhedkar, A. A. Impurity Profiling of Drugs towards Safety and Efficacy: Theory and Practice. J. Chil. Chem. Soc. 2017, 62, 3543–3557. DOI: 10.4067/S0717-97072017000200024.
   Web of Science ®Google Scholar
• Ahuja, S.; Alsante, K. M. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals; Academic Press: Massachusetts, 2003.
   Google Scholar
• Smith, R. J.; Webb, M. L. Analysis of Drug Impurities; John Wiley & Sons: New Jersey, 2008.
   Google Scholar
• Görög, S. The Importance and the Challenges of Impurity Profiling in Modern Pharmaceutical Analysis. TrAC: Trends. Analyt. Chem. 2006, 25, 755–757. DOI: 10.1016/j.trac.2006.05.011.
   Web of Science ®Google Scholar
• Khoshneviszadeh, R.; Fazly Bazzaz, B. S.; Rajabi, O. A Colorimetric Method to Measure the Amount of Hydroquinone in Liposomal Formulations. Trend. Pharm. Sci. 2019, 5, 87–92. DOI: 10.30476/TIPS.2019.81853.1007.
   Google Scholar
• Singh, S. Forensic Analysis of Compendial Articles: The Tightening Noose, EDQM, USPC, Anticipated Fallouts, GIT Lab. J. Eur. 2007, 11, 38.
   Google Scholar
• Glipizide Monograph. In EP, European Pharmacopoeia 6.0, 6th ed.; Council of Europe: Strasbourg, France, 2008; pp. 1977–1979.
   Google Scholar
• Available from: http://www.usp.org/usp-nf/pending-monographs. Accessed 19 Mar 2012.
   Google Scholar
• Bartos, D.; Gorog, S. Recent Advances in the Impurity Profiling of Drugs. CPA. 2008, 4, 215–230. DOI: 10.2174/157341208786306199.
   Google Scholar
• Liu, D. Q.; Wu, L.; Sun, M.; MacGregor, P. A. On-Line H/D Exchange LC-MS Strategy for Structural Elucidation of Pharmaceutical Impurities. J. Pharm. Biomed. Anal. 2007, 44, 320–329. DOI: 10.1016/j.jpba.2007.01.019.
   PubMed Web of Science ®Google Scholar
• Baertschi, S. W. Analytical Methodologies for Discovering and Profiling Degradation-Related Impurities. Trends. Analyt. Chem. 2006, 25, 758–767. DOI: 10.1016/j.trac.2006.05.012.
   Web of Science ®Google Scholar
• Sobhani, Z.; Emami, S. A.; Rajabi, O. Comparison between HPLC and HPTLC Densitometry for the Determination of Spinosin from Ziziphus Jujuba Mill. Fruit Extracts. J. Liq. Chromatogr. Relat. Technol. 2020, 43, 10–16. DOI: 10.1080/10826076.2019.1576140.
   Web of Science ®Google Scholar
• Ganorkar, A.; Gupta, K. Analytical Quality by Design: A Mini Review. Biomed. J. Sci. Tech. Res. 2017, 1, 1555–1559. DOI: 10.26717/BJSTR.2017.01.000484.
   Google Scholar
• Monks, K.; Rieger, H.-J.; Molnár, I. Expanding the Term “Design Space” in High Performance Liquid Chromatography (I)). J. Pharm. Biomed. Anal. 2011, 56, 874–879. DOI: 10.1016/j.jpba.2011.04.015.
   PubMed Web of Science ®Google Scholar
• Kamali, H.; Khodaverdi, E.; Hadizadeh, F.; Ghaziaskar, S. Optimization of Phenolic and Flavonoid Content and Antioxidants Capacity of Pressurized Liquid Extraction from Dracocephalum Kotschyi via Circumscribed Central Composite. J. Supercrit. Fluids. 2016, 107, 307–314. DOI: 10.1016/j.supflu.2015.09.028.
   Web of Science ®Google Scholar
• Baertschi, S. W.; Alsante, K. M.; Reed, R. A. Pharmaceutical Stress Testing: Predicting Drug Degradation; CRC Press: Florida, 2016.
   Google Scholar
• Alsante, K. M.; Friedmann, R. C.; Hatajik, T. D.; Lohr, L. L.; Sharp, T. R.; Snyder, K. D.; Szczesny, E. J. Degradation and Impurity Analysis for Pharmaceutical Drug Candidates. In Handbook of Modern Pharmaceutical Analysis. 2001, 3, 85–172.
   Google Scholar
• Kogawa, A. C.; Salgado, H. R. N. Impurities and Forced Degradation Studies: A Review. Curr. Pharm. Anal. 2016, 12, 18–24.
   Web of Science ®Google Scholar
• Ingale, S. J.; Sahu, C. M.; Paliwal, R. T.; Vaidya, S.; Singhai, A. K. Advance Approaches for the Impurity Profiling of Pharmaceutical Drugs: A Review. Int. J. Pharm. Life. Sci. 2011, 2, 955–962.
   Google Scholar
• Jain, D.; Basniwal, P. K. Forced Degradation and Impurity Profiling: Recent Trends in Analytical Perspectives. J. Pharm. Biomed. Anal. 2013, 86, 11–35. DOI: 10.1016/j.jpba.2013.07.013.
   PubMed Web of Science ®Google Scholar
• Shelke, M.; Deshpande, S. S.; Sharma, S. Quinquennial Review of Progress in Degradation Studies and Impurity Profiling: An Instrumental Perspective Statistics. Crit. Rev. Anal. Chem. 2020, 50, 226–253. DOI: 10.1080/10408347.2019.1615863.
   PubMed Web of Science ®Google Scholar
• Iliou, K.; Malenović, A.; Loukas, Y. L.; Dotsikas, Y. Analysis of Potential Genotoxic Impurities in Rabeprazole Active Pharmaceutical Ingredient via Liquid Chromatography-Tandem Mass Spectrometry, following Quality-By-Design Principles for Method Development. J. Pharm. Biomed. Anal. 2018, 149, 410–418. DOI: 10.1016/j.jpba.2017.11.037.
   PubMed Web of Science ®Google Scholar
• Filip, K.; Łaszcz, M.; Leś, A.; Chmiel, J. Process-Related Impurities of Eplerenone: Determination and Characterisation by HPLC Methods and Raman Spectroscopy. J. Pharm. Biomed. Anal. 2018, 159, 466–476. DOI: 10.1016/j.jpba.2018.07.028.
   PubMed Web of Science ®Google Scholar
• Zhuang, T.; Zhang, W.; Cao, L.; He, K.; Wang, Y.; Li, J.; Chen, L.; Liu, B.; Zhang, G. Isolation, Identification and Characterization of Two Novel Process-Related Impurities in Olanzapine. J. Pharm. Biomed. Anal. 2018, 152, 188–196. DOI: 10.1016/j.jpba.2018.01.026.
   PubMed Web of Science ®Google Scholar
• Arla, R. Development and Validation of Stability-Indicating Gas Chromatography Method for the Quantitative Determination of Ethylhexylglycerin and Its Impurities in Bulk and Pharmaceutical Dosage Forms. Asian. J. Pharm. 2018, 12, 243–250. DOI: 10.22377/ajp.v12i01.2068.
   Web of Science ®Google Scholar
• Magar, L. P.; Zaware, B. H.; More, K.; Sharma, B.; Shikhare, K.; Kamath, R.; Patil, P.; Gupta, L. Isolation, Synthesis and Characterization of Novel Process Related Impurities in Cetirizine Dihydrochloride by Mass and NMR Spectrometry. 2018.
   Google Scholar
• Wolff, F. C.; Dillenburg, T. L.; Venzon Antunes, M.; Linden, R.; Comparsi Wagner, S.; Verza, S. G. Characterization of Imatinib Mesylate Formulations Distributed in South American Countries: Determination of Genotoxic Impurities by UHPLC-MS/MS and dissolution profile . Biomed. Chromatogr. 2018, 32, e4222. DOI: 10.1002/bmc.4222.
   PubMed Web of Science ®Google Scholar
• Wu, W.; Tang, M.-H.; Tang, H.; Chen, K.; Fu, J.; Wang, L.; Xue, L.-L.; Peng, A.; Ye, H.; Chen, L.-J. Identification, Characterization and HPLC Quantification of Formulation-Related Impurities of Honokiol, an Antitumor Natural Drug Candidate in Clinical Trials. J. Pharm. Biomed. Anal. 2018, 153, 186–192. DOI: 10.1016/j.jpba.2018.02.033.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Zheng, S.; Xu, Y.; Hu, H.; Shen, M.; Tang, L. Development of a Novel HPLC Method for the Determination of the Impurities in Desonide Cream and Characterization of Its Impurities by 2D LC-IT-TOF MS. J. Pharm. Biomed. Anal. 2018, 161, 399–406. DOI: 10.1016/j.jpba.2018.08.055.
   PubMed Web of Science ®Google Scholar
• Devrukhakar, P. S.; M, S. S.; G, S.; R, S. Proposal of Degradation Pathway with Toxicity Prediction for Hydrolytic and Photolytic Degradation Products of Timolol. J. Pharm. Biomed. Anal. 2018, 154, 7–15. DOI: 10.1016/j.jpba.2018.02.057.
   PubMed Web of Science ®Google Scholar
• Wahl, O.; Cleynhens, J.; Verbruggen, A. M.; Holzgrabe, U. Impurity Profiling of N,N'-Ethylenebis-l-Cysteine Diethyl Ester (Bicisate). J. Pharm. Biomed. Anal. 2018, 150, 132–136. DOI: 10.1016/j.jpba.2017.11.078.
   PubMed Web of Science ®Google Scholar
• Van Heugten, A.; De Boer, W.; De Vries, W.; Markesteijn, C.; Vromans, H. Development and Validation of a Stability-Indicating HPLC-UV Method for the Determination of Triamcinolone Acetonide and Its Degradation Products in an Ointment Formulation. J. Pharm. Biomed. Anal. 2018, 149, 265–270. DOI: 10.1016/j.jpba.2017.11.026.
   PubMed Web of Science ®Google Scholar
• Kushwah, B. S.; Gupta, J.; Singh, D. K.; Kurmi, M.; Sahu, A.; Singh, S. Characterization of Solution Stress Degradation Products of Aliskiren and Prediction of Their Physicochemical and ADMET Properties. Eur. J. Pharm. Sci. 2018, 121, 139–154. DOI: 10.1016/j.ejps.2018.05.021.
   PubMed Web of Science ®Google Scholar
• Baira, S. M.; Sigalapalli, D. K.; Bathini, N. B.; Srinivas, R.; Talluri, M. K. LC/QTOF/MS/MS Characterization, Molecular Docking and In Silico Toxicity Prediction Studies on Degradation Products of Anagliptin. J. Pharm. Biomed. Anal. 2018, 159, 92–99. DOI: 10.1016/j.jpba.2018.06.036.
   PubMed Web of Science ®Google Scholar
• Yuan, Y.; Li, Y.-B.; Tai, Z.-F.; Xie, Y.-P.; Pu, X.-F.; Gao, J. Study of Forced Degradation Behavior of Pramlintide Acetate by HPLC and LC-MS. J. Food Drug Anal. 2018, 26, 409–415. DOI: 10.1016/j.jfda.2017.07.009.
   PubMed Web of Science ®Google Scholar
• Ghodke, S. S. Stability Indicating RP-HPLC Method for Simvastatin and Sitagliptin Phosphate with Degradation Studies in Marketed Pharmaceutical Hypo-Cholesterol and Antidiabetic Tablets. Int. J. Pharm. Chem. Bio. Sci. 2018, 08, 99–109.
   Google Scholar
• Saita, M. G.; Aleo, D.; Melilli, B.; Mangiafico, S.; Cro, M.; Sanfilippo, C.; Patti, A. pH-Dependent Stability of Azithromycin in Aqueous Solution and Structure Identification of Two New Degradation Products. J. Pharm. Biomed. Anal. 2018, 158, 47–53. DOI: 10.1016/j.jpba.2018.05.042.
   PubMed Web of Science ®Google Scholar
• Thummar, M.; Kuswah, B. S.; Samanthula, G.; Bulbake, U.; Gour, J.; Khan, W. Validated Stability Indicating Assay Method of Olaparib: LC-ESI-Q-TOF-MS/MS and NMR Studies for Characterization of Its New Hydrolytic and Oxidative Forced Degradation Products. J. Pharm. Biomed. Anal. 2018, 160, 89–98. DOI: 10.1016/j.jpba.2018.07.017.
   PubMed Web of Science ®Google Scholar
• Ragab, M. A.; Korany, M. A.; Galal, S. M.; Ahmed, A. R. Diode Array Detection for Stability Assessment and Evaluation of Degradation Kinetics of Newly Introduced Sacubitril in Its Supramolecular Complex (Lcz696) with Valsartan. J. Liq. Chromatogr. Relat. Technol. 2018, 41, 33–42. DOI: 10.1080/10826076.2017.1415213.
   Web of Science ®Google Scholar
• Baira, S. M.; Kalariya, P. D.; Nimbalkar, R.; Garg, P.; Srinivas, R.; Talluri, M. K. Characterization of Forced Degradation Products of Canagliflozine by Liquid Chromatography/Quadrupole Time-of-Flight Tandem Mass Spectrometry and In Silico Toxicity Predictions. Rapid Commun. Mass Spectrom. 2018, 32, 212–220. DOI: 10.1002/rcm.8032.
   PubMedGoogle Scholar
• Tiwari, S. K.; Singh, D. K.; Ladumor, M. K.; Chakraborti, A. K.; Singh, S. Study of Degradation Behaviour of Montelukast Sodium and Its Marketed Formulation in Oxidative and Accelerated Test Conditions and Prediction of Physicochemical and Admet Properties of Its Degradation Products Using Admet Predictor™. J. Pharm. Biomed. Anal. 2018, 158, 106–118. DOI: 10.1016/j.jpba.2018.05.040.
   PubMed Web of Science ®Google Scholar
• Bhole, R. P.; Tamboli, F. R. Development and Validation of Stability Indicating HPTLC-MS Method for Estimation of Empagliflozin in Pharmaceutical Dosage Form. Anal. Chem. Lett. 2018, 8, 244–256. DOI: 10.1080/22297928.2017.1404929.
   Google Scholar
• Chavan, B. B.; Vijaya Jyothi, P.; Kalariya, P. D.; Srinivas, R.; Talluri, M. V. N. K. Alcaftadine: Selective Separation and Characterization of Degradation Products by LC–QTOF-MS/MS. Chromatographia. 2018, 81, 631–638. DOI: 10.1007/s10337-018-3489-1.
   Web of Science ®Google Scholar
• Arous, B.; Al-Mardini, M. A.; Ghazal, H.; Al-Lahham, F. Stability-Indicating Method for the Determination of Rivaroxaban and Its Degradation Products Using LC-MS and TLC. Rese. J. Pharm. Technol. 2018, 11, 212–220. DOI: 10.5958/0974-360X.2018.00040.9.
   Google Scholar
• Guvvala, V.; Subramanian, V. C.; Anireddy, J. S.; Konda, M. Novel Degradation Products of Argatroban: Isolation, Synthesis and Extensive Characterization Using NMR and LC-PDA-MS/Q-TOF. J. Pharm. Anal. 2018, 8, 86–95. DOI: 10.1016/j.jpha.2017.07.001.
   PubMed Web of Science ®Google Scholar
• Can, N. Ö. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF. Molecules. 2018, 23, 1771. DOI: 10.3390/molecules23071771.
   PubMed Web of Science ®Google Scholar
• Samanthula, G.; Swain, D.; Sahu, G.; Bhagat, S.; Bharatam, P. Ultra HPLC Method for Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone: Identification and In Silico Toxicity Prediction of Degradation Products. J. Anal. Chem. 2018, 73, 560–569. DOI: 10.1134/S1061934818060138.
   Web of Science ®Google Scholar
• Nadella, N. P.; Ratnakaram, V. N.; Srinivasu, N. Development and Validation of UPLC Method for Simultaneous Quantification of Carvedilol and Ivabradine in the Presence of Degradation Products Using DOE Concept. J. Liq. Chromatogr. Relat. Technol. 2018, 41, 143–153. DOI: 10.1080/10826076.2018.1427595.
   Web of Science ®Google Scholar
• Thummar, M.; Swain, D.; Gananadhamu, S. Separation and Characterization of New Forced Degradation Products of Macitentan: A Dual Endothelin Receptor Antagonist. Chromatographia. 2018, 81, 525–531. DOI: 10.1007/s10337-018-3471-y.
   Web of Science ®Google Scholar
• Luo, Z.; Chen, X.; Wang, G.; Du, Z.; Ma, X.; Wang, H.; Yu, G.; Liu, A.; Li, M.; Peng, W.; Liu, Y. Development of a Validated HPLC Method for the Quantitative Determination of Trelagliptin Succinate and Its Related Substances in Pharmaceutical Dosage Forms. Eur. J. Pharm. Sci. 2018, 111, 458–464. DOI: 10.1016/j.ejps.2017.10.028.
   PubMed Web of Science ®Google Scholar
• Lu, Y.; Sun, X.; Song, F.; Wang, L.; Song, M.; Hang, T. Impurity Profiling of Varenicline Tartrate by LC-QTOF Mass Spectrometric Techniques during Drug Development. J. Pharm. Biomed. Anal. 2018, 155, 306–313. DOI: 10.1016/j.jpba.2018.03.055.
   PubMed Web of Science ®Google Scholar
• Lago, M. W.; Friedrich, M. L.; Iop, G. D.; Souza, d. T. B.; Azevedo Mello, d. P.; Adams, A. I. H. Capillary Zone Electrophoresis Method to Assay Tipranavir Capsules and Identification of Oxidation Product and Organic Impurity by Quadrupole-Time of Flight Mass Spectrometry. Talanta. 2018, 181, 182–189. DOI: 10.1016/j.talanta.2018.01.012.
   PubMed Web of Science ®Google Scholar
• Luo, Z.; Liu, A.; Liu, Y.; Wang, G.; Chen, X.; Wang, H.; Li, M.; Zhang, H.; Qiu, Y.; Zhai, H. Development of a Stability - Indicating HPLC Method for Simultaneous Determination of Ten Related Substances in Vonoprazan Fumarate Drug Substance. J. Pharm. Biomed. Anal. 2018, 149, 133–142. DOI: 10.1016/j.jpba.2017.11.011.
   PubMed Web of Science ®Google Scholar
• Gibala, P.; Douša, M.; Kalužíková, A.; Tkadlecová, M.; Štefko, M.; Kalášek, S.; Břicháč, J. Identification and Structure Elucidation of a New Degradation Impurity in the Multi-Component Tablets of Amlodipine Besylate. J. Pharm. Biomed. Anal. 2019, 162, 112–116. DOI: 10.1016/j.jpba.2018.07.040.
   PubMed Web of Science ®Google Scholar
• Wingert, N. R.; Ellwanger, J. B.; Bueno, L. M.; Gobetti, C.; Garcia, C. V.; Steppe, M.; Schapoval, E. E. Application of Quality by Design to Optimize a Stability-Indicating LC Method for the Determination of Ticagrelor and Its Impurities. Eur. J. Pharm. Sci. 2018, 118, 208–215. DOI: 10.1016/j.ejps.2018.03.029.
   PubMed Web of Science ®Google Scholar
• Kasimala, B. B.; Anna, V. R.; Mallu, U. R.; Reddy, M. Intended High-Performance Liquid Chromatography Procedure for the Quantification of Norfloxacin and Its Potential Impurities in Active Pharmaceutical Ingredient and Tablet Dosage Forms. Thai. J. Pharm. Sci. 2018, 42, 27–36.
   Google Scholar
• Mohan, T. S. S. J.; Mukkanti, K.; Jogia, H. A. Stability Indicating UHPLC Method Development and Validation for Estimation of Eltrombopag and Its Related Impurities in Tablet Dosage Form. Orient. J. Chem. 2018, 34, 1098–1104. DOI: 10.13005/ojc/340262..
   Web of Science ®Google Scholar
• Siva Kumar, R.; Sravan Kumar, K.; Kondareddy, L.; Yogeshwara, K.; Manish, G.; Jeenet, J.; Nitesh, K. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity. J. Chromatogr. Sci. 2018, 56, 383–395. DOI: 10.1093/chromsci/bmx084.
   PubMed Web of Science ®Google Scholar
• Abou Al-Alamein, A. M.; Abd El-Rahman, M. K.; Abdel-Moety, E. M.; Fawaz, E. M. Green HPTLC-Densitometric Approach for Simultaneous Determination and Impurity-Profiling of Ebastine and Phenylephrine Hydrochloride. Int. J. Pharm. Res. Technol. 2019, 147, 1097–1102. DOI: 10.1016/j.microc.2019.04.043.
   Google Scholar
• Schmidtsdorff, S.; Schmidt, A. H. Simultaneous Detection of Nitrosamines and Other Sartan-Related Impurities in Active Pharmaceutical Ingredients by Supercritical Fluid Chromatography. J. Pharm. Biomed. Anal. 2019, 174, 151–160. DOI: 10.1016/j.jpba.2019.04.049.
   PubMed Web of Science ®Google Scholar
• Kumar, V.; Bhurta, D.; Sharma, A.; Kumar, P.; Bharate, S. B.; Vishwakarma, R. A.; Bharate, S. S. Impurity Profiling of Anticancer Preclinical Candidate, IIIM-290. J. Pharm. Biomed. Anal. 2019, 166, 1–5. DOI: 10.1016/j.jpba.2018.12.027.
   PubMed Web of Science ®Google Scholar
• Nagadeep, J.; Kamaraj, P.; Arthanareeswari, M. Gradient RP-HPLC Method for the Determination of Potential Impurities in Dabigatran Etexilate in Bulk Drug and Capsule Formulations. Arab. J. Chem. 2019, 12, 3431–3443. DOI: 10.1016/j.arabjc.2015.09.006.
   Web of Science ®Google Scholar
• Kasagić-Vujanović, I.; Jančić-Stojanović, B. Quality by Design Oriented Development of Hydrophilic Interaction Liquid Chromatography Method for the Analysis of Amitriptyline and Its Impurities. J. Pharm. Biomed. Anal. 2019, 173, 86–95. DOI: 10.1016/j.jpba.2019.05.026.
   PubMed Web of Science ®Google Scholar
• Awasthi, A. K.; Kumar, L.; Tripathi, P.; Golla, M.; Reddy, C. S.; Kumar, P. Prospects to the Formation and Control of Potential Dimer Impurity E of pantoprazole sodium sesquihydrate. J. Pharm. Anal. 2019, 9, 170–177. DOI: 10.1016/j.jpha.2019.02.002.
   PubMed Web of Science ®Google Scholar
• Yang, W.; Yang, X.; Shi, F.; Liao, Z.; Liang, Y.; Yu, L.; Wang, R.; Li, Q.; Bi, K. Qualitative and Quantitative Assessment of Related Substances in the Compound Ketoconazole and Clobetasol Propionate Cream by HPLC-TOF-MS and HPLC. J. Pharm. Anal. 2019, 9, 156–162. DOI: 10.1016/j.jpha.2019.02.002.
   PubMed Web of Science ®Google Scholar
• He, L.; Qian, J.; Zhu, P.; Yang, W.; She, Y. Separation and Characterization of Unknown Impurities in Latamoxef Sodium by LC-Q-TOF MS and a Summary of Their Positive-Ion Fragmentation Regularities. J. Pharm. Biomed. Anal. 2019, 175, 112793. DOI: 10.1016/j.jpba.2019.112793.
   PubMed Web of Science ®Google Scholar
• Gopireddy, R. R.; Maruthapillai, A.; Devikala, S.; Tamilselvi, M.; Selvi, J. A.; Mahapatra, S. DoE Approach: A Validated Stability Indicating RP-HPLC Method Development for the Separation of Diasteromeric Analogs and Process Impurities of Carfilzomib. Mater. Today. Proc. 2019, 14, 514–531. DOI: 10.1016/j.matpr.2019.04.174.
   Google Scholar
• Kavitapu, D.; Maruthapillai, A.; Devikala, S.; Selvi, J. A.; Tamilselvi, M.; Mahapatra, S.; Kumar, G. P.; Tyagi, P. K. New Rapid Stability Indicating RP-UPLC Method for the Determination of Olaparib, Its Related Substances and Degradation Products in Bulk Drug and Dosage Form. Mater. Today. Proc. 2019, 14, 492–503. DOI: 10.1016/j.matpr.2019.04.172.
   Google Scholar
• Kongkiatpaiboon, S.; Duangdee, N.; Chewchinda, S.; Poachanukoon, O.; Amnuaypattanapon, K. Development and Validation of Stability Indicating HPLC Method for Determination of Adrenaline Tartrate. J. King. Saud. Univ. Sci. 2019, 31, 48–51. DOI: 10.1016/j.jksus.2017.05.016.
   Web of Science ®Google Scholar
• Chavan, B. B.; Sawant, V.; Borkar, R. M.; Ragampeta, S.; Talluri, M. K. Isolation and Structural Characterization of Degradation Products of Afatinib Dimaleate by LC-Q-TOF/MS/MS and NMR: Cytotoxicity Evaluation of Afatinib and Isolated Degradation Products. J. Pharm. Biomed. Anal. 2019, 166, 139–146. DOI: 10.1016/j.jpba.2019.01.004.
   PubMed Web of Science ®Google Scholar
• Guvvala, V.; Subramanian, V. C.; Anireddy, J. S. A Study on Structural Characterization of Degradation Products of Cangrelor Using LC/QTOF/MS/MS and NMR. J. Pharm. Biomed. Anal. 2019, 170, 327–334. DOI: 10.1016/j.jpba.2019.03.031.
   PubMed Web of Science ®Google Scholar
• Gumieniczek, A.; Berecka, A.; Mroczek, T.; Wojtanowski, K.; Dąbrowska, K.; Stępień, K. Determination of Chemical Stability of Sitagliptin by LC-UV, LC-MS and FT-IR Methods. J. Pharm. Biomed. Anal. 2019, 164, 789–807. DOI: 10.1016/j.jpba.2018.11.023.
   PubMed Web of Science ®Google Scholar
• Venkateswararao, Y.; Sujana, K. A Novel Stability Indicating RP-HPLC Method Development and Validation for the Determination of Clopidogrel in Bulk and Its Dosage Forms. Int. J. Pharm. Res. Technol. 2019, 09, 1–11.
   Google Scholar
• Azar, Z. J.; Afshar, M. Development and Validation of a Stability-Indicating Ion-Pair RP-HPLC Method for Determination of Bethanechol with UV Detection: Application to Pharmaceutical Analysis. Pharm. Chem. J. 2019, 53, 376–382. DOI: 10.1007/s11094-019-02008-w.
   Web of Science ®Google Scholar
• Baira, S. M.; Srinivas, R.; Talluri, M. K. Identification and Structural Characterization of Hydrolytic Degradation Products of Alvimopan by LC/QTOF/MS/MS and NMR studies. J. Pharm. Biomed. Anal. 2019, 165, (399–409. DOI: 10.1016/j.jpba.2018.12.035.
   PubMed Web of Science ®Google Scholar
• Veerubhotla, K.; Walker, R. Development and Validation of a Stability-Indicating RP-HPLC Method Using Quality by Design for Estimating Captopril. Pharm. Sci. 2019, 81, 45–56. DOI: 10.4172/pharmaceutical-sciences.1000478.
   Web of Science ®Google Scholar
• Swarupa, P. G.; Prasad, K.; Babu, K. S.; Kumar, J. S. Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Escitalopram and L-Methylfolate in Bulk and Tablet Dosage Form. RJC. 2019, 12, 2338–2347. DOI: 10.31788/RJC.2019.1245438.
   Google Scholar
• Campbell, J. M.; Grinias, K.; Facchine, K.; Igne, B.; Clawson, J.; Peterson, J.; Wolters, A.; Barry, J.; Watson, S.; Leach, K. Analysis of Unstable Degradation Impurities of a Benzodiazepine and Their Quantification without Isolation Using Multiple Linear Regression. J. Pharm. Biomed. Anal. 2019, 167, 1–6. DOI: 10.1016/j.jpba.2019.01.028.
   PubMed Web of Science ®Google Scholar
• Vajjha, S.; Bommuluri, V.; Mohan P, K. V. K.; Rumalla, C. S.; Doddipalla, R.; Kaliyaperumal, M.; Korupolu, R. B. Degradation Studies of Ibrutinib under Stress Conditions: Characterisation and Structural Elucidation of Novel Degradants. J. Pharm. Biomed. Anal. 2019, 172, 9–17. DOI: 10.1016/j.jpba.2019.04.010.
   PubMed Web of Science ®Google Scholar
• Zezula, M.; Ruszczak, M.; Maruszak, W.; Zagrodzka, J.; Chodynski, M.; Dams, I. Dams, I. Development and Validation of the Stability Indicating RP-UHPLC Method for the Determination of the Chemical Purity and Assay of Bimatoprost. J. Pharm. Biomed. Anal. 2019, 174, 348–359. DOI: 10.1016/j.jpba.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Sversut, R. A.; Vieira, J. C.; Kassab, N. M.; Silva, D. B.; Salgado, H. R. N. Forced Degradation Behavior of Two-Drug Combinations: Isolation and Characterization of Major Degradation Products by LC-MS. Microchem. J. 2019, 150, 104074. DOI: 10.1016/j.microc.2019.104074.
   Web of Science ®Google Scholar
• Ye, Q.; Huang, Y.; Grier, S.; Miller, S. A. Oxidative Degradation Pathways of Beclabuvir Hydrochloride Mediated by Hydrogen Peroxide and UV/VIS Light. J. Pharm. Biomed. Anal. 2019, 172, 388–394. DOI: 10.1016/j.jpba.2019.05.017.
   PubMed Web of Science ®Google Scholar
• Deng, Y.; Chen, X.; Wang, L.; Peng, X.; Lin, M. Characterization of Unknown Impurities in Coenzyme Q10 Using LC-MS and NMR. J. Pharm. Biomed. Anal. 2019, 175, 112771. DOI: 10.1016/j.jpba.2019.07.019.
   PubMed Web of Science ®Google Scholar
• Gad, M.; Hassan, S. A.; Zaazaa, H. E.; Amer, S. M. Multivariate Development and Optimization of Stability Indicating Method for Determination of Daclatasvir in Presence of Potential Degradation Products. Chromatographia. 2019, 82, 1641–1652. DOI: 10.1007/s10337-019-03793-y.
   Web of Science ®Google Scholar
• Deshpande, N.; Kamble, P.; Kulkarni, S.; Gawande, V. Optimized and Validated Stability Indicating RP-HPLC Method for Estimation of Nadolol. Pharm. Chem. J. 2019, 53, 1–9. DOI: 10.1007/s11094-020-02146-6.
   Web of Science ®Google Scholar
• Gu, X.; Chen, Y.; Lou, Y.; Zheng, J. Separation and Characterization of Forced Degradation Products in Homoharringtonine Injection by UHPLC-Q-TOF-MS. J. Pharm. Biomed. Anal. 2019, 176, 112801. DOI: 10.1016/j.jpba.2019.112801.
   PubMed Web of Science ®Google Scholar
• Saida, S. J.; Manikandan, A.; Kaliyaperumal, M.; Rumalla, C. S.; Khan, A. A.; Jayaraman, V. B.; Yanaka, R.; Rao, S. V. Identification, Isolation and Characterization of Dolutegravir Forced Degradation Products and Their Cytotoxicity Potential. J. Pharm. Biomed. Anal. 2019, 174, 588–594. DOI: 10.1016/j.jpba.2019.06.022.
   PubMed Web of Science ®Google Scholar
• Abd Elrahman, M. K.; Houssini, O. M. E.; Fahem, D. K.; Zaazaa, H. E. Stability Indicating Liquid Chromatography Method for the Analysis of Vecuronium Bromide: Study of the Degradation Profile. Heliyon. 2020, 6, e03530. DOI: 10.1016/j.heliyon.2020.e03530.
   PubMed Web of Science ®Google Scholar
• Hussein, L. A.; Magdy, N. N.; Ibrahim, M. A. Stability-Indicating RP-UPLC Method for Simultaneous Determination of Azilsartan Medoxomil and Chlorthalidone in Tablets in the Presence of Its Degradation Products. J. Chromatogr. Sci. 2019, 57, 213–219. DOI: 10.1093/chromsci/bmy102.
   PubMed Web of Science ®Google Scholar
• Otašević, B.; Šljivić, J.; Protić, A.; Maljurić, N.; Malenović, A.; Zečević, M. Comparison of AQbD and Grid Point Search Methodology in the Development of Micellar HPLC Method for the Analysis of Cilazapril and Hydrochlorothiazide Dosage Form Stability. Microchem. J. 2019, 145, 655–663. DOI: 10.1016/j.microc.2018.11.033.
   Web of Science ®Google Scholar
• Xu, Q. Advancing USP Compendial Methods for Fixed Dose Combinations: A Case Study of Metoprolol Tartrate and Hydrochlorothiazide Tablets. J. Pharm. Anal. 2019, 9, 77–82. DOI: 10.1016/j.jpha.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Fernandes, A. A Validated Stability Indicating RP-HPLC Method for Estimation of Tolfenamic Acid in Presence of Its Pharmacopoeial Impurities. Int. J. Appl. Biol. Pharm. 2019, 11, 264–270. DOI: 10.22159/ijap.2019v11i5.34606..
   Google Scholar
• Dos Santos Moreira, C.; Lourenço, F. R. Development and Optimization of a Stability-Indicating Chromatographic Method for Verapamil Hydrochloride and Its Impurities in Tablets Using an Analytical Quality by Design (AQbD) Approach. Microchem. J. 2020, 154, 104610. DOI: 10.1016/j.microc.2020.104610.
   Web of Science ®Google Scholar
• Carje, A. G.; Balint, A.; Ion, V.; Pop, A. L.; Muntean, D.-L.; Sabău, R.; Imre, S. HPLC-UV Method Approach for the Analysis and Impurity Profiling of Captopril. Stud. U. Babes-BolL. Che. 2019, 64, 231–242. DOI: 10.24193/subbchem.2019.2.19.
   Web of Science ®Google Scholar
• Palakeeti, B.; Ramesh, T.; Reddy, K. V.; Konakanchi, R.; Rao, P. N.; Gobi, K. V. Identification and Characterisation of Rucaparib Degradation Products and Their Comparison with Known Impurities. Chromatographia. 2019, 82, 591–604. DOI: 10.1007/s10337-018-3669-z.
   Web of Science ®Google Scholar
• Mallu, U. R.; Venkateswara Rao, A.; Kasimala, B. B. Rapid Stability Indicating HPLC Method for the Analysis of Leflunomide and Its Related Impurities in Bulk Drug and Formulations. Turk. J. Pharm. Sci. 2019, 16, 457–465. DOI: 10.4274/tjps.galenos.2018.34635.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Zhou, J.; Xu, Y.; Zhu, B.; Jin, Y. Characterization of Two Unknown Impurities in Roxithromycin by 2D LC-QTOF/MS/MS and NMR. J. Pharm. Biomed. Anal. 2020, 184, 113196. DOI: 10.1016/j.jpba.2020.113196.
   PubMed Web of Science ®Google Scholar
• Pasquini, B.; Orlandini, S.; Furlanetto, S.; Gotti, R.; Del Bubba, M.; Boscaro, F.; Bertaccini, B.; Douša, M.; Pieraccini, G. Quality by Design as a Risk-Based Strategy in Pharmaceutical Analysis: Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nintedanib and Its Impurities. J. Chromatogr. A. 2020, 1611, 460615. DOI: 10.1016/j.chroma.2019.460615.
   PubMed Web of Science ®Google Scholar
• Li, Q.; Huang, Y.; Zhang, Y.; Cui, H.; Yin, L.; Li, Y.; Yuan, A.; Hu, Y.; Wu, J. A Novel HPLC Method for Analysis of Atosiban and Its Five Related Substances in Atosiban Acetate Injection. J. Pharm. Biomed. Anal. 2020, 177, 112808. DOI: 10.1016/j.jpba.2019.112808.
   PubMed Web of Science ®Google Scholar
• Liao, S.; Chen, H.; Wang, G.; Wu, S.; Yang, Z.; Luo, W.; Liu, Z.; Gao, X.; Qin, J.; Li, C-h.; Wang, Z. Identification, Characterization, Synthesis and Strategy for Minimization of Potential Impurities Observed in the Synthesis of Brivaracetam. Tetrahedron. 2020, 76, 131273. DOI: 10.1016/j.tet.2020.131273.
   Web of Science ®Google Scholar
• Liu, G.; Zhu, B.; Ren, X.; Wang, J. Characterization of 28 Unknown Impurities in 16-Membered Macrolides by Liquid Chromatography Coupled with Ion Trap/Time-Of-Flight Mass Spectrometry. J. Pharm. Biomed. Anal. 2020, 186, 113324. DOI: 10.1016/j.jpba.2020.113324.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Sahu, A.; Balhara, A.; Singh, I. P.; Kulkarni, S.; Singh, N. K.; Garg, P.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 11: Characterization of Interaction Products of Zidovudine and Efavirenz, and Evaluation of Their anti HIV-1 Activity, and Physiochemical and ADMET Properties. J. Pharm. Biomed. Anal. 2020, 178, 112911. DOI: 10.1016/j.jpba.2019.112911.
   PubMed Web of Science ®Google Scholar
• Wang, C.; Dong, H.; Liu, H.; Sun, Z.; Yuan, A.; Wu, J.; Hu, Y. Using HPLC to Analyze (S)-Oxiracetam and Four Related Substances in the Bulk Drug of (S)-Oxiracetam. J. Pharm. Biomed. Anal. 2020, 180, 113072. DOI: 10.1016/j.jpba.2019.113072.
   PubMed Web of Science ®Google Scholar
• Christofi, M.; Markopoulou, C. K.; Tzanavaras, P. D.; Zacharis, C. K. UHPLC-Fluorescence Method for the Determination of Trace Levels of Hydrazine in Allopurinol and Its Formulations: Validation Using Total-Error Concept. J. Pharm. Biomed. Anal. 2020, 187, 113354. DOI: 10.1016/j.jpba.2020.113354.
   PubMed Web of Science ®Google Scholar
• Wu, P.; Li, M.; Kan, Y.; Wu, X.; Li, H. Impurities Identification and Quantification for Calcitonin Salmon by Liquid Chromatography-High Resolution Mass Spectrometry. J. Pharm. Biomed. Anal. 2020, 186, 113271. DOI: 10.1016/j.jpba.2020.113271.
   PubMed Web of Science ®Google Scholar
• Ruggenthaler, M.; Grass, J.; Schuh, W.; Huber, C. G.; Reischl, R. Impurity Profiling of liothyronine sodium by Means of Reversed Phase HPLC, High Resolution Mass Spectrometry, on-Line H/D Exchange and UV/VIS Absorption. J. Pharm. Biomed. Anal. 2017, 143, 147–158. DOI: 10.1016/j.jpba.2017.05.039.
   PubMed Web of Science ®Google Scholar
• Johnsirani, P.; Wani, A. A.; Bharatam, P. V.; Nanjappan, S. LC-ESI-QTOF-MS Analysis Utilizing Gas-Phase Fragmentation Reactions Subjected to ESI-IS-CID and ESI-CID-MS/MS Conditions to Study the Degradation Behaviour of Sorafenib Tosylate: NMR and in Vitro Cytotoxicity and Apoptosis Detection Studies of Hydrolytic Degradation Products. J. Pharm. Biomed. Anal. 2020, 177, 112881. DOI: 10.1016/j.jpba.2019.112881.
   PubMed Web of Science ®Google Scholar
• Singh, D. K.; Sahu, A.; Balhara, A.; Giri, S.; Singh, S. Insights into the Degradation Chemistry of Tazarotene, a Third Generation Acetylenic Retinoid: LC-HRMS (Orbitrap), LC-MSn and NMR Characterization of Its Degradation Products, and Prediction of Their Physicochemical and ADMET properties. J. Pharm. Biomed. Anal. 2020, 186, 113316. DOI: 10.1016/j.jpba.2020.113316.
   PubMed Web of Science ®Google Scholar
• Prajapati, K. J.; Kothari, C. S. First Report on Clorprenaline HCL Degradation Products: Identification and Characterization by LC–MS/MS. J. Iran. Chem. Soc. 2020, 17, 1027–1039. DOI: 10.1007/s13738-019-01831-y.
   Web of Science ®Google Scholar
• Chen, L.; Chen, J.; Lu, M.; Stämpfli, A. Simultaneous Determination of Elbasvir and Grazoprevir in Fixed-Dose Combination and Mass Spectral Characterization of Each Degradation Product by UHPLC-ESI-QTOF-MS/MS. J. Pharm. Biomed. Anal. 2020, 178, 112964. DOI: 10.1016/j.jpba.2019.112964.
   PubMed Web of Science ®Google Scholar
• Saraf, I.; Modhave, D.; Kushwah, V.; Neshchadin, D.; Gescheidt, G.; Trausinger, G.; Melchior, P.; Magnes, C.; Paudel, A. Feasibility of Rapidly Assessing Reactive Impurities Mediated Excipient Incompatibility Using a New Method: A Case Study of Famotidine-PEG System. J. Pharm. Biomed. Anal. 2020, 178, 112893. DOI: 10.1016/j.jpba.2019.112893.
   PubMed Web of Science ®Google Scholar
• Aleo, D.; Saita, M. G.; Spitaleri, F.; Sanfilippo, C.; Patti, A. Degradation Profile of Nepafenac in Aqueous Solution and Structural Characterization of a Novel Degradation Product. J. Pharm. Biomed. Anal. 2020, 189, 113432. DOI: 10.1016/j.jpba.2020.113432.
   PubMed Web of Science ®Google Scholar
• Gad, M. A.; Amer, S. M.; Zaazaa, H. E.; Hassan, S. A. Strategies for Stabilizing Formulation and QbD Assisted Development of Robust Stability Indicating Method of Azilsartan Medoxomil/Chlorthalidone. J. Pharm. Biomed. Anal. 2020, 178, 112910. DOI: 10.1016/j.jpba.2019.112910.
   PubMed Web of Science ®Google Scholar
• Jenkins, D.; Harmon, C. L.; Jia, X.; Kesselring, A.; Hatcher, D.; Grayson, K.; Ayres, J. Forced Degradation Studies of Medroxyprogesterone Acetate Injectable Suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques. J. Pharm. Biomed. Anal. 2020, 187, 113352. DOI: 10.1016/j.jpba.2020.113352.
   PubMed Web of Science ®Google Scholar
• Ragi, N. C.; Velma, G. R.; Pallerla, P. K.; Siddiqua, S.; Alugonda, V.; Rachamalla, H. K. R.; Pabbaraja, S.; Sripadi, P. Identification and Characterization of Forced Degradation Products of Vortioxetine by LC/MS/MS and NMR. J. Pharm. Biomed. Anal. 2020, 188, 113442. DOI: 10.1016/j.jpba.2020.113442.
   PubMed Web of Science ®Google Scholar
• Thalluri, B.; Dhiman, V.; Tiwari, S.; Baira, S. M.; Talluri, M. K. Study on Forced Degradation Behaviour of Dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic Explanations of Hydrolytic, Oxidative and Photocatalytic Rearrangement of Degradation Products. J. Pharm. Biomed. Anal. 2020, 179, 112985. DOI: 10.1016/j.jpba.2019.112985.
   PubMed Web of Science ®Google Scholar
• Mital, N. P.; Charmy, K.; Vivek, V. An Innovative Impurity Profiling of Avanafil Using LC and LC-MS/MS with In-Silico Toxicity Prediction. Arab. J. Chem. 2020, 13, 6493–6509. DOI: 10.1016/j.arabjc.2020.06.007.
   Web of Science ®Google Scholar
• Douša, M.; Doubský, J.; Gajdošová, M.; Tkadlecová, M.; Martinů, T.; Jireš, J. Detection and Structure Elucidation of the New Degradation Impurities in the Pharmaceutical Formulations of Ruxolitinib Hydrobromide. J. Pharm. Biomed. Anal. 2020, 186, 113266. DOI: 10.1016/j.jpba.2020.113266.
   PubMed Web of Science ®Google Scholar
• Moura, F. C. S.; Dos Santos Machado, C. L.; Paula, F. R.; Couto, A. G.; Ricci, M.; Cechinel-Filho, V.; Bonomini, T. J.; Sandjo, L. P.; Bresolin, T. M. B. Taxifolin Stability: In Silico Prediction and In Vitro Degradation with HPLC-UV/UPLC-ESI-MS Monitoring . J. Pharm. Anal. 2021, 11, 232–240. DOI: 10.1016/j.jpha.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Takyi-Williams, J.; Erasmus, L.; Hayeshi, R.; Grobler, A. Development and Validation of an LC-MS/MS Method for the Quantification of Goserelin in a Pheroid® Formulation, in Simulated Intestinal Fluid. J. Pharm. Biomed. Anal. 2020, 180, 113044. DOI: 10.1016/j.jpba.2019.113044.
   PubMed Web of Science ®Google Scholar
• Ganorkar, S. B.; Vander Heyden, Y.; Shirkhedkar, A. A.; Lokwani, D. K.; Dhumal, D. M.; Bobade, P. S. Pharmaceutical Analysis Combined with In-Silico Therapeutic and Toxicological Profiling on Zileuton and Its Impurities to Assist in Modern Drug Discovery. J. Pharm. Biomed. Anal. 2020, 179, 112982. DOI: 10.1016/j.jpba.2019.112982.
   PubMed Web of Science ®Google Scholar
• Palakurthi, A. K.; Dongala, T.; Katakam, L. N. R. QbD Based Development of HPLC Method for Simultaneous Quantification of Telmisartan and Hydrochlorothiazide Impurities in Tablets Dosage Form. Pract. Lab. Med. 2020, 21, e00169. DOI: 10.1016/j.plabm.2020.e00169.
   PubMedGoogle Scholar
• Tantawy, M. A.; Weshahy, S. A.; Wadie, M.; Rezk, M. R. Stability-Indicating HPTLC Method for the Simultaneous Detection and Quantification of Alfuzosin Hydrochloride, Solifenacin Succinate along with Four of Their Official Impurities. Microchem. J. 2020, 157, 104905. DOI: 10.1016/j.microc.2020.104905.
   Web of Science ®Google Scholar
• De Souza Barbosa, F.; Pezzi, L. C.; Tsao, M.; Macedo, S. M. D.; De Oliveira, T. F.; Schapoval, E. E.; Mendez, A. S. Stability in Clinical Use and Stress Testing of Meropenem Antibiotic by Direct Infusion ESI-Q-TOF: Quantitative Method and Identification of Degradation Products. J. Pharm. Biomed. Anal. 2020, 179, 112973. DOI: 10.1016/j.jpba.2019.112973.
   PubMed Web of Science ®Google Scholar
• Narenderan, S.; Ramesh, J.; Babu, B.; Meyyanathan, S. A Stability-Indicating LC-MS/MS Method Optimization for Pemetrexed Through Design of Experiments: Identification and Characterization of Major Oxidative Degradation Product. J. Pharm. Biomed. Anal. 2020, 183, 113150. DOI: 10.1016/j.jpba.2020.113150.
   PubMed Web of Science ®Google Scholar
• Tol, T.; Tawde, H.; Gorad, S.; Jagdale, A.; Kulkarni, A.; Kasbale, A.; Desai, A.; Samanta, G. Optimization of a Liquid Chromatography Method for the Analysis of Related Substances in Daclatasvir Tablets Using Design of Experiments Integrated with the Steepest Ascent Method and Monte Carlo Simulation. J. Pharm. Biomed. Anal. 2020, 178, 112943. DOI: 10.1016/j.jpba.2019.112943.
   PubMed Web of Science ®Google Scholar
• Alkhateeb, F. L.; Wilson, I.; Maziarz, M.; Rainville, P. Ultra High-Performance Liquid Chromatography Method Development for Separation of Formoterol, Budesonide, and Related Substances Using an Analytical Quality by Design Approach. J. Pharm. Biomed. Anal. 2021, 193, 113729. DOI: 10.1016/j.jpba.2020.113729.
   PubMed Web of Science ®Google Scholar
• Chen, Y.; Li, H.; Hong, H.; Tao, H.; Peng, X.; Xu, G. Isolation and Characterization of Novel Process-Related Impurities in Empagliflozin. J. Pharm. Biomed. Anal. 2021, 198, 114001. DOI: 10.1016/j.jpba.2021.114001.
   PubMed Web of Science ®Google Scholar
• Guo, N.; He, Q.; Jin, Y.; Hou, Z.; Pan, Y.; Liu, J.; Sun, C. Separation and Characterization of Impurity P in Azithromycin Product. J. Pharm. Biomed. Anal. 2021, 195, 113853. DOI: 10.1016/j.jpba.2020.113853.
   PubMed Web of Science ®Google Scholar
• Luo, M.; Zheng, L.; Wang, S.; Zhu, J.; Tang, Z.; Gao, P. Characterization of Four Major Degradation Products in Metformin by 2D LC-QTOF/MS/MS. J. Pharm. Biomed. Anal. 2021, 192, 113662. DOI: 10.1016/j.jpba.2020.113662.
   PubMed Web of Science ®Google Scholar
• Mehta, L.; Naved, T.; Grover, P.; Bhardwaj, M.; Mukherjee, D. LC and LC-MS/MS Studies for Identification and Characterization of New Degradation Products of Ibrutinib and Elucidation of Their Degradation Pathway. J. Pharm. Biomed. Anal. 2021, 194, 113768. DOI: 10.1016/j.jpba.2020.113768.
   PubMed Web of Science ®Google Scholar
• Dhiman, V.; Balhara, A.; Singh, S.; Tiwari, S.; Gananadhamu, S.; Talluri, M. K. Characterization of Stress Degradation Products of Nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a Degradation Product with a Structure Alert for Mutagenicity. J. Pharm. Biomed. Anal. 2021, 199, 114037. DOI: 10.1016/j.jpba.2021.114037.
   PubMed Web of Science ®Google Scholar
• Krait, S.; Wissenbach, D. K.; Peters, F. T.; Scriba, G. K. HPLC-MS Identification of Acid Degradation Products of Dolutegravir. J. Pharm. Biomed. Anal. 2021, 197, 113954. DOI: 10.1016/j.jpba.2021.113954.
   PubMed Web of Science ®Google Scholar
• Sahu, A. K.; Goswami, A.; Kate, A. S.; Sengupta, P. Identification and Structural Characterization of Potential Degraded Impurities of Ribociclib by Time of flight-tandem mass Spectrometry, and Their Toxicity Prediction . J. Pharm. Biomed. Anal. 2021, 197, 113933. DOI: 10.1016/j.jpba.2021.113933.
   PubMed Web of Science ®Google Scholar
• Jeelani, S.; Soukhova, N. Development and Validation of a Stability Indicating HPLC Method for Organic Impurities of Erythromycin Stearate Tablets. J. Pharm. Biomed. Anal. 2021, 195, 113858. DOI: 10.1016/j.jpba.2020.113858.
   PubMed Web of Science ®Google Scholar
• Han, X.; Cheng, F-j.; Di, B.; Xu, H.; Song, M.; Hang, T-j.; Lu, Y.-T. Identification and Characterization of New Impurities in Zopiclone Tablets by LC-QTOF-MS. J. Pharm. Biomed. Anal. 2021, 199, 114056. DOI: 10.1016/j.jpba.2021.114056.
   PubMed Web of Science ®Google Scholar
• Singh, S.; Handa, T.; Narayanam, M.; Sahu, A.; Junwal, M.; Shah, R. P. A Critical Review on the Use of Modern Sophisticated Hyphenated Tools in the Characterization of Impurities and Degradation Products. J. Pharm. Biomed. Anal. 2012, 69, 148–173. DOI: 10.1016/j.jpba.2012.03.044.
   PubMed Web of Science ®Google Scholar
• Imatani, K. Advances in Q-TOF LC/MS Systems for Pharma Applications. Available from: www.iptonline.com/articles/public/P30-32%20non-print.pdf. 2012.
   Google Scholar
• Colson, K. L. Ultracool NMR Technology. Mod. Drug Discov. 2003, 47–51.
   Google Scholar
• Kovacs, H.; Moskau, D.; Spraul, M. Cryogenically Cooled Probes-a Leap in NMR Technology. Prog. Nucl. Magn. Reson. Spectrosc. 2005, 46, 131–155. DOI: 10.1016/j.pnmrs.2005.03.001.
   Web of Science ®Google Scholar
• Cai, J.; Henion, J. Capillary Electrophoresis-Mass Spectrometry. J. Chromatogr. A. 1995, 703, 667–692. DOI: 10.1016/0021-9673(94)01178-H.
   Web of Science ®Google Scholar